Tomohisa Yamamoto

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis

Takuji Okusaka, Masahiro Yoshida, Masayuki Kitano et al. · International Journal of Clinical Oncology · 2023 · 171 citations · Full text

Medicine, Oncology, Surgery +17

Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis

Sohei Satoi, Tsutomu Fujii, Hiroaki Yanagimoto et al. · Annals of Surgery · 2016 · 111 citations · Full text

Medicine, Oncology, Pharmacology +16

Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer

Tomohisa Yamamoto, Hiroaki Yanagimoto, Sohei Satoi et al. · Pancreas · 2011 · 100 citations

Life Sciences, Cancer Biology, Immunology +17

Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.

K Morishige, Hiroshi Kurachi, Kyoka Amemiya et al. · PubMed · 1991 · 88 citations

Life Sciences, Molecular Biology, Oncology +16

A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi et al. · European Journal of Cancer · 2022 · 85 citations · Full text

Medicine, Oncology, Pharmacology +12